ReviewOpen forum infectious diseases2021

Meta-analysis of Clinical Outcomes Using Ceftazidime/Avibactam, Ceftolozane/Tazobactam, and Meropenem/Vaborbactam for the Treatment of Multidrug-Resistant Gram-Negative Infections.

Geneva M Wilson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.